Tilray Brands, Inc. (TLRY)
6.55
+0.41
(+6.68%)
USD |
NASDAQ |
Apr 02, 16:00
6.51
-0.04
(-0.61%)
After-Hours: 20:00
Tilray Brands EPS Diluted (Quarterly) : -0.2358 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0139 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.23M |
| Revenue (Quarterly) | 206.73M |
| Total Expenses (Quarterly) | 233.30M |
| Enterprise Value | 780.30M |
| Gross Profit Margin (Quarterly) | 24.11% |
| Profit Margin (Quarterly) | -12.21% |
| Earnings Yield | -208.6% |
| Normalized Earnings Yield | -52.28 |